Abstract
Posterior uveitis can occur in all age-groups and often has devastating effects on vision. The visual loss can have a variety of causes including cataract formation, vitritis, optic nerve damage and macular oedema. In patients with active inflammatory disease resulting in reduced vision, steroids are still the best drug but cyclosporin is becoming widely used in combination with steroid theraphy, in patients who do not respond to steroids alone or in whom the dose of steroids required to control the disease process is unacceptably high.
Cyclosporin works specifically on activated T-lymphocytes and does not therefore result in bone marrow suppression like the more conventional immunosuppressive drugs.
This paper discusses the indications for treatment in patients with posterior uveitis and how to use steroids, cyclosporin and other immunosuppressive drugs in the management of this condition.
Similar content being viewed by others
Article PDF
References
Lightman S and Chan C : Immune mechanisms in choroidoretinal inflammation. Eye 1990, 4: 345–53.
Cohen I and Wekerle H : Autoimmunity, self-recognition, and blocking factors. In ‘Autoimmunity: Genetic, Immunologic, Virologic and Clinical Aspects’: ed Talal N. 1977, Academic Press NY.
Rang HP and Dale MM : Glucorcorticoids. In: ‘Pharmacology’ eds Rang and Dale p 394–402. Churchill Livingstone.
Russin MM, Tessher HH, Cunha-Vas JG : Posterior subtenon injection of corticosteroids in uveitis patients with cystoid macula oedema. Jpn J Oph-thalmol 1988, 34 :385–91.
Towler H, Cliffe A, Whitting P, Forrester J : Low dose cyclosporin A therapy in chronic posterior uveitis. Eye 1989, 3: 282–87.
Borel JV and Ryffel B : The mechanism of action of cyclosporin: A continuing puzzle. In: Schindler, R. ed. Cyclosporin in Autoimmune Diseases. Berlin: Springer-Verlag, 1986, pp. 24–31.
Calne RY : Immunosuppression for organ-grafting: Observations on cyclosporin A. Immunol Rev 1979, 46: 113–28.
Thompson AW and Webster LM : The influence of cyclosporin A on cell mediated immunity. Clin Exp Immunol 1988, 71: 369–76.
Nussenblatt RB, Palestine AG, Chan CC : Cyclosporin-A therapy in the treatment of intra-ocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983 , 93 :275–81.
Palestine AG, Austin HA, Barlow JE, Autonouych TT, Sabins SG, Prems HE, Nussenblatt RB : Renal histopathologic alterations in patients treated with cyclosporin for uveitis. N Eng J Med 1986, 314: 1293–8.
Van Eraffenried B and Krupp B : Side effects of cyclosporin in renal transplant recipients and in pateints with autoimmune disease. Transplant Proc 1986, 18: 876–83.
Shaw L : Critical issues in cyclosporin monitoring: Report of the task force on cyclosporin monitoring. Clin Chem 1987, 33: 1629–88.
Binder AI, Graham EM, Sanders MD, Dinning W, James WG, Denman AM : Cyclosporin A in the treatment of severe Behçet's disease. Brit J Rheumatol 1987, 26 :285–91.
Tabbara KF : Chlorambucil in Behçet's disease: A reappraisal. Ophthalmology 1983, 90: 906–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lightman, S. Use of steroids and immunosuppressive drugs in the management of posterior uveitis. Eye 5, 294–298 (1991). https://doi.org/10.1038/eye.1991.46
Issue Date:
DOI: https://doi.org/10.1038/eye.1991.46
Keywords
This article is cited by
-
‘Steroid treatment card’ compliance is suboptimal but can be improved
Eye (2010)
-
Recent Perspectives in Ocular Drug Delivery
Pharmaceutical Research (2009)
-
Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation
Japanese Journal of Ophthalmology (2008)
-
Ocular vasculitis
Current Rheumatology Reports (2003)
-
The role of azathioprine in the management of retinal vasculitis
Eye (1998)